Antipsychotic Equivalent Doses Calculator
Estimate approximate chlorpromazine equivalents and cross convert between common antipsychotics using a fast clinical reference tool. This calculator is designed for education and medication review support, not for direct prescribing without clinical judgment, patient history, and monitoring.
Dose conversion calculator
Enter a current antipsychotic dose, then click Calculate equivalents to see the estimated chlorpromazine equivalent and comparable doses across other agents.
Expert guide to using an antipsychotic equivalent doses calculator
An antipsychotic equivalent doses calculator is a clinical support tool that helps translate one antipsychotic dose into an approximate comparable dose of another agent. The most common framework is chlorpromazine equivalence, sometimes abbreviated as CPZ equivalents. In this system, a given dose of haloperidol, risperidone, olanzapine, quetiapine, or another antipsychotic is mapped against the dose of chlorpromazine expected to produce a broadly similar antipsychotic effect. The method is not perfect, but it creates a common scale for comparing potency across drugs that differ substantially in receptor binding, half life, sedation burden, and side effect profile.
Clinicians, pharmacists, trainees, and researchers use dose equivalence estimates for several reasons. First, they support medication review when a regimen appears very high or very low. Second, they can help structure a switch from one medication to another. Third, they allow more consistent interpretation of antipsychotic burden across studies, audits, and quality improvement work. Finally, they help communicate intensity of treatment in a language that remains understandable across different medications and formulations. Still, it is essential to remember that dose equivalence is a starting point, not a final prescribing instruction.
Why dose equivalence matters in practice
Antipsychotics vary enormously in milligram potency. For example, a few milligrams of haloperidol can correspond to a much larger number of milligrams of quetiapine. Without an equivalence framework, simple milligram to milligram comparison can be misleading. A patient taking 300 mg of quetiapine is not receiving thirty times the antipsychotic effect of a patient taking 10 mg of olanzapine. Those numbers represent different potency scales. A calculator converts each dose to a shared reference point and makes the comparison clinically meaningful.
Equivalence calculations are especially useful when treatment teams are assessing polypharmacy, reviewing adherence, planning inpatient to outpatient transitions, or evaluating whether side effects might reflect cumulative dopamine blockade. If a regimen contains multiple antipsychotics, estimating the chlorpromazine equivalent burden can clarify how intense the total exposure may be. This does not prove effectiveness or toxicity on its own, but it gives the clinician a more standardized way to think about the regimen.
What this calculator actually estimates
This calculator starts with a practical approximation: the amount of each drug that corresponds to roughly 100 mg of chlorpromazine. Once the reference value is known, any entered dose can be converted into estimated chlorpromazine equivalents. Then the same chlorpromazine equivalent can be translated into comparable doses of other agents. Mathematically, the process has two steps:
- Convert the entered medication dose into chlorpromazine equivalents.
- Convert the chlorpromazine equivalent value into target antipsychotic doses.
If 2 mg of haloperidol is treated as approximately equivalent to 100 mg of chlorpromazine, then 10 mg of haloperidol would correspond to roughly 500 mg chlorpromazine equivalent. If the target is olanzapine and 5 mg olanzapine is treated as approximately equal to 100 mg chlorpromazine, then 500 mg chlorpromazine equivalent would translate to around 25 mg of olanzapine. This is a useful comparative estimate, but it does not guarantee the same real world response or tolerability in a given patient.
Important limitations every clinician should remember
- Equivalent antipsychotic effect does not mean equivalent side effects. Sedation, akathisia, EPS, orthostasis, QT effects, anticholinergic burden, prolactin elevation, and metabolic liability all differ.
- Switching is rarely a direct overnight swap. Cross tapering, washout, or overlap strategies may be needed depending on relapse risk and adverse effect burden.
- Clozapine is particularly difficult to compare using simple equivalence methods because its superior efficacy in treatment resistant schizophrenia and unique safety profile do not fit neatly into a single potency ratio.
- Long acting injectables require formulation specific conversion rules and timing logic that are not captured by a standard oral equivalence table.
- Patient specific variables such as age, smoking, renal or hepatic function, CYP interactions, and prior response can shift the practical dose needed.
Selected comparison table: approximate chlorpromazine equivalence reference points
The table below shows common approximate oral dose reference points used in many educational discussions. These are simplified estimates intended for comparison, not definitive product labeling.
| Antipsychotic | Approximate dose equivalent to 100 mg chlorpromazine | General potency impression | Clinical note |
|---|---|---|---|
| Chlorpromazine | 100 mg | Reference standard | Useful anchor for cross drug comparison. |
| Haloperidol | 2 mg | High potency | Relatively low milligram dose can represent substantial dopamine blockade. |
| Risperidone | 2 mg | Moderate to high potency | Prolactin elevation and EPS risk may become more prominent with dose increases. |
| Olanzapine | 5 mg | Moderate potency | Commonly associated with weight gain and metabolic effects. |
| Quetiapine | 75 mg | Lower milligram potency | Sedation profile means antipsychotic effect is not the only driver of dose selection. |
| Aripiprazole | 7.5 mg | High functional potency | Partial agonism makes clinical comparisons less intuitive than simple D2 blockade models. |
| Clozapine | 50 mg | Special case | Do not rely on equivalence alone when switching to or from clozapine. |
| Ziprasidone | 60 mg | Lower milligram potency | Absorption depends on food intake for oral capsules. |
Clinical burden statistics that explain why careful dose comparison matters
The need for accurate antipsychotic review is not academic. Schizophrenia spectrum illnesses, bipolar disorder, and related severe mental illnesses create a large treatment burden, and antipsychotics are central to care. Public health data make this clear.
| Measure | Statistic | Why it matters for dose comparison |
|---|---|---|
| Estimated prevalence of schizophrenia in U.S. adults | Approximately 0.25% to 0.64% | Even a relatively low prevalence condition represents many patients receiving long term antipsychotic therapy. |
| Annual prevalence of bipolar disorder in U.S. adults | About 2.8% | Antipsychotics are used across schizophrenia and bipolar disorder, making cross drug understanding broadly relevant. |
| Adults with serious mental illness in the United States | Millions of adults each year | Medication optimization has large real world implications for safety, function, and health system utilization. |
| Metabolic monitoring importance | Weight, glucose, and lipids are standard follow up targets in many patients on second generation agents | Equivalent efficacy does not mean equivalent metabolic risk, so conversion must be paired with monitoring plans. |
How to interpret the output from this calculator
When you enter a source drug and daily dose, the calculator estimates the chlorpromazine equivalent burden first. That number is useful because it acts as a neutral comparison scale. Then the tool displays the estimated corresponding doses for other medications. In practical terms, this lets you ask questions such as:
- Is the proposed replacement dose in the same general antipsychotic intensity range as the current regimen?
- If a patient reports adverse effects, is the total antipsychotic burden unexpectedly high once translated to chlorpromazine equivalents?
- If multiple prescribers or settings are involved, does the current regimen appear internally consistent when compared on a standard scale?
Use the output as a framework for further thinking, not as a complete switching protocol. For example, if a patient is stable on olanzapine but developing metabolic complications, the equivalent dose of another antipsychotic may identify a reasonable target range for discussion. However, the final decision must also account for prior relapse pattern, target symptoms, insomnia, agitation, adherence history, substance use, and vulnerability to akathisia or EPS.
Common scenarios where dose equivalence is helpful
- Hospital discharge planning: An inpatient team can compare the effective inpatient dose with a proposed outpatient medication to avoid accidental underdosing or overdosing.
- Antipsychotic switch because of side effects: If one drug causes weight gain, prolactin elevation, or sedation, equivalent comparison can define a rational starting range for the replacement.
- Polypharmacy review: Converting two antipsychotics into a common chlorpromazine equivalent language can reveal total burden more clearly than raw milligram totals.
- Teaching and audit work: Trainees and quality teams can compare prescribing intensity more consistently across patients and across units.
Why equivalent doses do not guarantee equal outcomes
Antipsychotic medications differ in ways that a single conversion ratio cannot fully capture. Some have stronger histamine blockade and cause more sedation. Others have greater propensity for akathisia or prolactin elevation. Some have clinically relevant food requirements, while others are strongly affected by smoking through CYP1A2 induction. Receptor kinetics also matter. A chlorpromazine equivalent estimate may describe antipsychotic potency in a broad sense, but it does not replicate the whole experience of the source drug.
This is especially important during switching. A patient who tolerates 20 mg of olanzapine may not feel equally well on the chlorpromazine equivalent of another medication, even if the arithmetic looks correct. The switch might produce insomnia, agitation, activation, withdrawal dyskinesia, rebound cholinergic symptoms, or a re emergence of psychosis if the crossover is too fast. For that reason, clinicians typically interpret equivalent doses together with a titration schedule and a monitoring strategy.
Best practices when using an antipsychotic dose calculator
- Confirm whether the source and target doses are oral, immediate release, extended release, or long acting injectable. Formulation matters.
- Use the calculator to estimate a range, then compare with guideline recommendations and product labeling.
- Review renal function, hepatic function, age, smoking status, and interacting medications before finalizing a plan.
- Pay special attention to clozapine transitions, prior neuroleptic sensitivity, and history of NMS, severe EPS, or marked metabolic complications.
- Document the rationale for the switch, expected benefits, and objective outcomes to monitor after the change.
Authoritative resources for further reading
- National Institute of Mental Health: Schizophrenia statistics
- National Institute of Mental Health: Bipolar disorder statistics
- MedlinePlus: Antipsychotic medicines overview
Bottom line
An antipsychotic equivalent doses calculator can save time and improve consistency when comparing medications, estimating total treatment burden, or planning a switch. Its greatest value is as a structured reference that converts unlike milligram doses into a shared framework. Its greatest limitation is that real patients are more complex than any potency table. The safest and most clinically useful approach is to combine equivalence data with symptom targets, past treatment response, formulation details, medical comorbidity, and close follow up after any medication change.